Is blood transfusion therapy the ideal treatment for ?-Thalassemia Intermedia?
The thalassemias represent the most common single gene disorder worldwide. The total annual incidence of symptomatic individuals with ?-thalassemia is estimated at 1 in 100,000 throughout the world (1) of which nearly 10% have ?-thalassemia intermedia (TI) (2). Several approaches have been used for...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
PAGEPress Publications
2014-08-01
|
| Серии: | Mediterranean Journal of Hematology and Infectious Diseases |
| Предметы: | |
| Online-ссылка: | https://mjhid.org/index.php/mjhid/article/view/1685 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
